Top 50 Medical Startup Investors in Israel (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
OurCrowd
VC Fund
|
12 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $604k–$65M |
|
Pontifax
VC Fund
|
10 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$128M |
|
Israel Innovation Authority
VC Fund
|
6 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $140k–$5M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
HBL Hadasit Bio Holdings
VC Fund
|
4 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Triventures
VC Fund
|
4 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | $6M–$28M |
|
Trendlines Group
VC Fund
|
4 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
Terra Venture Partners
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $1M–$30M |
|
aMoon Fund
VC Fund
|
3 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Docor International Management
VC Fund
|
3 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
3 | Israel, United States | Series A, Series C, Series B | Health Care, Medical, Medical Device | $4.4M–$55M |
|
Robin Hood Ventures
VC Fund
|
3 | United States, Israel | Seed, Series A | Software, Health Care, Biotechnology | $100k–$11M |
|
Good Company
VC Fund
|
3 | Israel, United States | Seed, Pre-Seed, Series A | Software, Social Impact, Artificial Intelligence | $400k–$22M |
|
SeedIL Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $1.7M–$21M |
|
Grove Ventures
VC Fund
|
2 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
OrbiMed
VC Fund
|
2 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$151M |
|
Elron Ventures
VC Fund
|
2 | Israel, United States, China | Seed, Series A | Information Technology, Software, Cyber Security | $1M–$17M |
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $300k–$21M |
|
LionBird
VC Fund
|
2 | United States, Israel, India | Seed, Series A, Series B | Health Care, Software, Artificial Intelligence | $1.3M–$40M |
|
NFX
VC Fund
|
2 | United States, Israel, United Kingdom | Seed, Series A, Pre-Seed | Software, Information Technology, Marketplace | |
|
Technion Seed
VC Fund
|
2 | Israel, United States | Series A, Seed | Medical, Health Care, Big Data | $750k–$12M |
|
Dov Moran
Angel
|
2 | Israel, United States | Series A, Seed, Series B | Semiconductor, Hardware, Health Care | |
|
DEFTA Partners
VC Fund
|
2 | United States, Israel, Japan | Series A, Series B | Biotechnology, Medical, Software | |
|
Mindset Ventures
VC Fund
|
2 | United States, Israel, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Machine Learning | |
|
Shmuel Cabilly
Angel
|
2 | Israel, United States | Series B, Series C | Health Care, Medical, Artificial Intelligence | |
|
TechWald Holding S.p.A.
VC Fund
|
2 | Israel, Switzerland, United States | Series A, Series B, Series C | Health Care, Medical, Medical Device | $3.6M–$60M |
|
XTX Ventures
VC Fund
|
2 | United Kingdom, United States, Israel | Series A, Seed | Artificial Intelligence, Software, Machine Learning | |
|
Prof. Rafael Beyar
Angel
|
2 | Israel | Seed, Series A | Medical, Medical Device, Machine Learning | |
|
Champel Capital
VC Fund
|
2 | Israel, United States, Switzerland | Series B, Series A, Seed | Artificial Intelligence, Health Care, Software | |
|
SCP Vitalife Partners
VC Fund
|
2 | Israel, United States | Series C, Series D | Health Care, Medical, Medical Device | $1.2M–$43M |
|
Tal Ventures
VC Fund
|
2 | Israel, United States, Cyprus | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $3M–$120M |
|
S2G Ventures
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B | Food and Beverage, Agriculture, Biotechnology | |
|
Neo Ventures
VC Fund
|
2 | Israel, United Kingdom, Estonia | Seed, Series A | Software, Artificial Intelligence, Aerospace | |
|
Indaco Venture Partners
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Rimonci Capital
VC Fund
|
2 | Israel | Series A, Series B, Series C | Health Care, Medical Device, Medical | |
|
Flerie Invest
VC Fund
|
2 | Sweden, Israel, Iceland | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Shimon Eckhouse
Angel
|
2 | Israel | Seed | Medical, Biotechnology, Fitness | |
|
Yozma Group
VC Fund
|
2 | Israel, United States, South Korea | Series B, Seed | Health Care, Medical, Software | $400k–$59M |
|
Clal Biotechnology Industries
VC Fund
|
2 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical | $4M–$55M |
|
Mithril Capital Management
VC Fund
|
2 | United States, United Kingdom, Israel | Series C, Series B, Series D | Software, Health Care, Information Technology | $10M–$300M |
|
Firstime Venture Capital
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $500k–$21M |
|
ZORA Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Biotechnology, Health Care, Internet | $1M–$8.1M |
|
Arkin Holdings
VC Fund
|
2 | Israel, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$95M |
|
Connecticut Innovations
VC Fund
|
2 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $300k–$25M |
|
CE Ventures (CEIIF)
VC Fund
|
2 | Israel, United States, India | Series B, Series A, Series C | Software, Analytics, Big Data | $4M–$40M |
|
Marius Nacht
Angel
|
2 | Israel, United States, Germany | Series A, Seed, Series B | Artificial Intelligence, Health Care, Machine Learning | $3M–$120M |
|
Zohar Gilon
Angel
|
2 | Israel, United States | Seed, Series A, Series B | Software, Internet, Health Care | $1.5M–$15M |
|
HealthpointCapital
VC Fund
|
2 | Israel, United States | Series B, Series C | Medical, Biotechnology, Manufacturing | $5M–$15M |
|
Eclipse
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B, Seed | Software, Robotics, Artificial Intelligence | $2M–$105M |
| Access all 503 investors in Israel Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 286
- Round size: Seed $604k–$10M; Series A $5.3M–$22M; Series B $7M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Oriient — Bringing the GPS revolution indoors with the most scalable and accessible solution for buildings. No Hardware, Cost Effective, and Highly Accurate.
- Sequentify — Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications.
- BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 113
- Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
- Graviton Bioscience — Curing Disease through Restored Homeostasis
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 183
- Round size: Seed $500k–$5M; Grant $140k–$3.5M; Pre-Seed $150k–$2.1M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Q-Factor —
- GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
- Inspira Technologies — Inspira Technologies is an innovative Medical Technology Company focused on the acute respiratory care market. The ART, Inspira’s novel technology, can address the unmet need of providing acute respiratory treatment that prevents mechanical ventilation while patients are awake and breathing spontaneously.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $6M–$24M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $650k–$4.1M; Series A $2.3M–$15M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $31M in 2013
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 77
- Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series C, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 149
- Round size: Seed $210k–$4.3M; Series A $100k–$11M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Epoxy.ai — We make sports viewing and gaming easy and fun for everyone
- Lia — LIA Diagnostics is redesigning pregnancy tests to addresses the challenges surrounding privacy, usability and sustainability in current pregnancy tests.
- Beckon Ice cream — Beckon is calling people back to REAL ice cream that is unbelievably delicious and surprisingly lactose-free. Founded on the belief that n...
Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.
Show more...Investment focus
- Industry: Software, Social Impact, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 20
- Round size: Seed $700k–$22M; Pre-Seed $400k–$4.8M; Series A $5M–$17M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
We invest in the best Israeli founders. Boutique seed-stage VC with personalized support and international connections.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $1.7M–$8M; Series A $2.2M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BlinqIO — Autonomously develop and maintain flawless automation code, combining Generative AI's power with human oversight for scalable testing solutions
- Quack — Get your team the power to resolve user issues right away.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 71
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 614
- Round size: Series A $10M–$140M; Series B $24M–$151M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Fusion Pharmaceuticals — Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre.Fusion’s deepradiochemistry expertise presents a technology platform that can be replicated to turn internalizing antibodies that have previously demonstrated limited clinical efficacy into highly effective cytotoxic drugs. Fusion’s ability to link the most effective isotopes to the targeting antibody allows for the creation of optimized agents for both diagnostic imaging and radioimmunotherapy (Precision Medicine). Following positive tumor identification with the imaging agent, treatment with the antibody linked to a therapeutic isotope delivers a cytotoxic payload into the cancer cell.Fusion’s lead product candidate, FPX-01, is a precision RIT that is a product of this innovative approach. FPX-01 has been designed to internalize into targeted cancer cells and deliver a lethal and highly localized radioactive payload. The precise targeting of this radiolabeled antibody causes selective and extremely effective cytotoxicity of tumor cells at relatively low doses of radioactivity.
- LifeCell International — LifeCell is a research-driven healthcare company with a range of top-notch preventive care & diagnostics services on offer. With more than 3,00,000 happy customers so far, LifeCell is India's largest & most trusted stem cell bank, having state-of-the-art laboratories at Chennai & Gurgaon and a network spread over 200 service centres in the country.
- Harvest Integrated Research Organization — Harvest IRO is a Modern Global CRO providing integrated clinical research organization services and regulatory-ready execution worldwide.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 65
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Cybersixgill — Cybersixgill is the leader in cyber threat intelligence enablement and enrichment. Their fully automated threat intelligence solutions help organizations fight cyber crime, detect phishing, data leaks, fraud and vulnerabilities as well as amplify incident response – in real-time. The Cybersixgill Investigative Portal empowers security teams withcontextual and actionable insights as well as the ability to conduct real-time investigations. Rich data feeds such as Darkfeed™ and DVE Score™ harness Cybersixgill’s unmatched intelligence collection capabilities and deliver real-time intel into organizations' existing security systems. Most recently, Cybersixgill introduced agility to threat intel with their CI/CP methodology (Continuous Investigation/Continuous Protection). Current customers include enterprises, financial services, MSSPs, governments and law enforcement entities.
- CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
- Brainsgate — Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.BrainsGate's platform...
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 43
- Round size: Seed $2.2M–$12M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Kimba — Heal your mind, improve your sleep, and boost your health with Kimba's AI scent technology. Join Kimba and start sleeping better today!
- Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
- Shifters AI — Shifters AI is a software company that develops artificial intelligence and robotic solutions.
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, India
Investor stats
- Total investments: 71
- Round size: Seed $1.3M–$17M; Series A $3.5M–$19M; Series B $6.5M–$40M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $85M in 2022
Portfolio highlights
- FlipOS — Stoa partners with real estate investors who buy, renovate and sell single family homes. We fund their deals, create the renovation scope and purchase the properties from them at the end of the renovation. Our proprietary technology allows us to significantly shorten the process without compromising the quality of service.
- Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
- Rhino Federated Computing —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are a VC firm investing in pre-seed and seed stage startups. We back exceptional Founders building market-transforming companies.
Show more...Investment focus
- Industry: Software, Information Technology, Marketplace
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 271
- Lead/follow: no public data
Portfolio highlights
- Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
- Gizmo — AI quizzes that help you learn and remember anything
- Stoke Space — STOKE Space Technologies seamlessly connecting earth and space.
Technion Seed is a seed-stage investment firm, owned jointly by four top-tier Venture Capital funds – Vertex Venture Capital, Battery Ventures (US-based), SCP-Vitalife and ProSeed – and the Technion Research & Development Foundation. Through Technion Seed, these funds invest in high market potential technological ideas and ventures, thatare still at an early stage and with very high uncertainty. The investment in such ventures – initially up to about $1,000,000 – is made both directly by the funds and indirectly through Technion Seed. The purpose of the initial investment is to enable the entrepreneurs to prove the viability of their idea. Success in the initial phase will then lead to a large round of financing by the funds, for continued growth of the venture. Technion Seed and its owners invest in a wide variety of areas, including communications, IT, internet, medical devices, renewable energy, new materials and more.
Show more...Investment focus
- Industry: Medical, Health Care, Big Data
- Stage:Series A, Seed
- Geography: Israel, United States
Investor stats
- Total investments: 8
- Round size: Seed $800k–$4M; Series A $750k–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aren — Aren is an AI-powered platform that empowers engineers and asset owners to assess and manage civil infrastructure while minimizing the risk of failure and optimizing budgets. Its technology offers a cost-effective, automated, and quantitative approach to de-risk the asset management practice using computer vision and machine learning.
- VineSight — Protect your Brand, Cause, Campaign, Organization. Spot and eliminate attacks before they go viral.
- Envizion Medical — ENvizion Medical is now ENvue Medical. Enhanced Navigation. Expanded Vision. Same technology Same team New company ENvizion Medical is now ENvue Medical. Enhanced Navigation. Expanded Vision.
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more...Investment focus
- Industry: Semiconductor, Hardware, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 24
- Lead/follow: no public data
Portfolio highlights
- Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage information technology companies with global opportunities to accelerate growth. DEFTA has offices and partners in the United States, Japan, Israel and the United Kingdom. via: DEFTA Partners
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Series A, Series B
- Geography: United States, Israel, Japan
Investor stats
- Total investments: 31
- Lead/follow: no public data
Portfolio highlights
- InformAI — InformAI builds business analytics and artificial intelligence-based solutions for industry-leading healthcare organizations, medical device companies and imaging/PACS companies to improve mission outcome and operational improvement. The company provides computer consulting, artificial intelligence-based software solutions for imageclassification, natural language processing for operational processes, and prediction algorithms for mission-critical applications.InformAI develops AI-enabled healthcare diagnostic-assist tools and patient outcome predictors for leading healthcare systems and national physician groups. The company's AI software enables faster patient diagnoses at the point of care and improved patient outcome risk analysis.
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Endogena — Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
Mindset Ventures is an early-stage VC firm that supports entrepreneurs in their growth and international expansion. The firm targets B2B startups technology applied to Agriculture, Financial Services, Healthcare, Cybersecurity, Education, and Enterprise Software industry. It was founded in 2016 and headquartered in Sao Paulo, Brazil.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 94
- Lead/follow: no public data
Portfolio highlights
- Apono — Apono makes permission management to applications, infrastructure, and data repositories simple, secure and compliant.
- Music AI — State-of-the-art ethical AI solutions for audio and music applications. The highest quality audio separation available.
- Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, Switzerland, United States
Investor stats
- Total investments: 9
- Round size: Series A $3.6M–$7.1M; Series B $8.5M–$20M; Series C $9.3M–$60M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- iGent — iGent AI focus on integrating advanced AI capabilities into the software development process.
- Verax AI — Seeks to be the leading provider of enterprise-grade trust solutions for Generative AI, enabling companies worldwide to build or adopt any Generative AI agent with confidence
- Prior Labs — Prior Labs is developing innovative foundation models that understand spreadsheets and databases.
Prof. Rafael Beyar
Show more...Investment focus
- Industry: Medical, Medical Device, Machine Learning
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
As a young and dynamic company with a spirit of entrepreneurship, we look first and foremost at the vision leading the entrepreneur. We believe that we should be investing in people, before everything else. We want to be investing in companies led by entrepreneurs who are capable of envisioning and growing great companies with products and/or services meeting real market needs in large and growing markets.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Lynxight — Lynxight creates computer vision applications for underwater operations. The company offers a platform with a set of applications utilized across multiple industries: pools, aquaculture, energy, maritime security and infrastructure, among others. Powered by proprietary AI technology, Lynxight enables superior capabilities to manage safety risksand improve operational performance: object detection, measurement and recognition, behavioral analysis, action classification, trajectory optimization and anomaly modeling to predict and forewarn of unplanned situations.Lynxight is hardware agnostic and can be applied in any environment using imaging from above/below water.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- Intelligent Traffic Control — Intelligent Traffic Control is an adaptive AI-based traffic light real-time management system. It uses advance Supervised and Unsupervised Machine Learning algorithms to make a real-time analysis of the intersection situation, recognize the traffic pattern and tendencies, and changing the green light allocation per lane accordingly, assuringminimum waiting time at the intersection by maximizing the intersection capability.ITC mathematically proved that there are many traffic jams that the system can prevent. It accumulates the algorithm based on a complex mathematical equation and set of algorithms.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series C, Series D
- Geography: Israel, United States
Investor stats
- Total investments: 12
- Round size: Series C $10M–$25M; Series D $1.2M–$43M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS). The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
- Ivenix — Bring the power of guided workflows, adaptive fluid delivery, and complete secondary delivery with an Ivenix IV Infusion System. Explore now.
- Lifeward — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 56
- Round size: Seed $3M–$12M; Series A $5M–$25M; Series B $35M–$120M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
- Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 159
- Lead/follow: no public data
Portfolio highlights
- Catalera — Catalera BioSolutions offers proprietary bio-based pest control products to enhance the well-being of people, plants, and planet.
- Exacto — Exacto is an innovative turnkey adjuvant manufacturer for agricultural, T&O and industrial vegetation management markets.
- Amperage — Amperage provides a full-service platform that focuses on directly investing and growing broadband infrastructure.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Aerospace
- Stage:Seed, Series A
- Geography: Israel, United Kingdom, Estonia
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible.
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design createdthe desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability.No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide.After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
A dedicated to China-Israel cross border investment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Series C
- Geography: Israel
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
- BELKIN Vision — Imagine an efficient, non-contact glaucoma laser treatment able to alleviate IOP painlessly. Accessible Glaucoma Care at the touch of a button.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Sweden, Israel, Iceland
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Shimon Eckhouse
Show more...Investment focus
- Industry: Medical, Biotechnology, Fitness
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series B, Seed
- Geography: Israel, United States, South Korea
Investor stats
- Total investments: 25
- Round size: Seed $400k–$4.5M; Series B $2.5M–$59M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- BiSiChem — Invent targeted small molecule drugs that are either first-in-class or second-generation
- RoomGenie — An AI-powered chatbot for hotels revolutionizes the way guests interact with in-room services by enabling seamless cross-selling and upselling. Integrated within smart devices or hotel apps, this AI solution leverages natural language processing (NLP) to communicate with guests in a conversational and personalized manner.From booking spatreatments and restaurant reservations to upgrading rooms or scheduling late checkouts, the chatbot intuitively identifies guest preferences and suggests relevant services. It analyzes data such as guest profiles, previous stays, and real-time behavior to deliver tailored recommendations, boosting both guest satisfaction and revenue.Available 24/7, the chatbot ensures instant responses to guest inquiries, reducing dependence on front-desk staff and enhancing operational efficiency. Additionally, it supports multiple languages, catering to a global clientele and making communication barrier-free. Hotels can integrate the AI chatbot with their property management systems (PMS) and point-of-sale (POS) platforms to streamline service delivery and track guest interactions.The solution empowers hotels to provide a hyper-personalized, tech-forward experience, which appeals to modern travelers. By automating cross-selling and upselling opportunities while improving guest engagement, the chatbot not only enhances the overall stay experience but also drives incremental revenue, making it a vital tool for the hospitality industry.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4M–$55M; Series B $15M–$33M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mithril is a family of long-term venture capital funds agnostic to sector and geography. We invest and partner with teams who use technology to build valuable and lasting businesses, often in industries long overdue for change.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series C, Series B, Series D
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 68
- Round size: Series B $10M–$150M; Series C $15M–$142M; Series D $15M–$300M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $850M in 2017
Portfolio highlights
- Neocis — Yomi, a dental robot, is the next generation in implant surgery that can give patients a better experience, expand your offerings and boost your efficiency
- GreyOrange — Learn about GreyOrange 2026 from GreyOrange, where AI-driven warehouse and retail store solutions reduce costs, increase accuracy and power omnichannel success.
- Helion Energy — Enabling a future with unlimited clean energy
Firstime Ventures is investing in companies who are building a sustainable & accessible future for all.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $600k–$6M; Series A $500k–$10M; Series B $5M–$21M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
- Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
- STAX Engineering, Inc. — The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 14
- Round size: Seed $1M–$7M; Series A $4M–$8.1M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 31
- Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $270M in 2021
Portfolio highlights
- Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 259
- Round size: Seed $300k–$5.3M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- 1touch.io — By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you,1touch.io can track it for you.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- LegiTime Technologies — Miami Embracing New Technology and Safety
CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
Show more...Investment focus
- Industry: Software, Analytics, Big Data
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, India
Investor stats
- Total investments: 34
- Round size: Series A $4M–$7M; Series B $4M–$30M; Series C $10M–$40M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
- Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $3M–$120M; Series A $5M–$23M; Series B $8M–$83M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
- BioGenCell — Ushering in a New EraIn Cellular Medicine Making personalized cell-therapy a reality for every patient with a degenerative microvascular disease.
- 1E Therapeutics — 1E Therapeutics is a breakthrough, drug development company creating RNA-targeting therapeutics based on a proprietary drug design platform.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more...Investment focus
- Industry: Software, Internet, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 33
- Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 7
- Round size: Series B $5M–$13M; Series C $12M–$15M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.
Show more...Investment focus
- Industry: Software, Robotics, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 209
- Round size: Seed $2M–$30M; Series A $9.1M–$55M; Series B $15M–$105M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $510M in 2023
Portfolio highlights
- Syng — Syng is an audio company transforming the human relationship with sound. their hardware and software platform gives creators and listeners the power to engage with, explore, and share sound in transformative new ways.
- Nucleus RadioPharma — Founded by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools.
- Watchmaker Genomics — Watchmaker Genomics believes that the most exciting innovations lie at the intersection of biology, engineering, and computer science.
Medical Investor funding in Israel at a glance
Stats across 422 deals from 503 investors.
Access all 503 investors in Israel Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 503 investors investing in Israel Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!